Wakamoto Pharmaceutical Co Ltd (4512)

Currency in JPY
314.0
+1.0(+0.32%)
Closed·
4512 Scorecard
Full Analysis
Stock generally trades with low price volatility
4512 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
311.0317.0
52 wk Range
209.0377.0
Key Statistics
Bid/Ask
313.00 / 314.00
Prev. Close
313
Open
315
Day's Range
311-317
52 wk Range
209-377
Volume
265.3K
Average Volume (3m)
312.79K
1-Year Change
28.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4512 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Wakamoto Pharmaceutical Co Ltd Company Profile

Wakamoto Pharmaceutical Co.,Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation; and Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

Employees
403
Market
Japan

Compare 4512 to Peers and Sector

Metrics to compare
4512
Peers
Sector
Relationship
P/E Ratio
0.0x−1.6x−0.5x
PEG Ratio
0.000.030.00
Price/Book
0.0x1.6x2.6x
Price / LTM Sales
0.0x2.1x3.3x
Upside (Analyst Target)
0.0%82.0%40.3%
Fair Value Upside
Unlock−2.9%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -6.38%
Dividend Yield
0.96%
Industry Median 2.48%
Annualised payout
3.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4512 Income Statement

FAQ

What Stock Exchange Does Wakamoto Pharmaceutical Trade On?

Wakamoto Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Wakamoto Pharmaceutical?

The stock symbol for Wakamoto Pharmaceutical is "4512."

What Is the Wakamoto Pharmaceutical Market Cap?

As of today, Wakamoto Pharmaceutical market cap is 10.92B.

What Is Wakamoto Pharmaceutical's Earnings Per Share (TTM)?

The Wakamoto Pharmaceutical EPS (TTM) is -6.38.

When Is the Next Wakamoto Pharmaceutical Earnings Date?

Wakamoto Pharmaceutical will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is 4512 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Wakamoto Pharmaceutical Stock Split?

Wakamoto Pharmaceutical has split 1 times.

How Many Employees Does Wakamoto Pharmaceutical Have?

Wakamoto Pharmaceutical has 403 employees.

What is the current trading status of Wakamoto Pharmaceutical (4512)?

As of 16 Aug 2025, Wakamoto Pharmaceutical (4512) is trading at a price of 314.00, with a previous close of 313.00. The stock has fluctuated within a day range of 311.00 to 317.00, while its 52-week range spans from 209.00 to 377.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.